OneMedPlace Interviews Richard T. Schumacher, CEO of Pressure Biosciences
Pressure Biosciences CEO Rick Schumacher discusses the company’s proprietary technology and the high-profile clients that are using it.
FDA Approves Vermillion’s Ovarian Cancer Test
The U.S. Food and Drug Administration has approved a blood test to detect ovarian cancer and help physicians decide what kind of surgery should be done and by whom.
Syneron and Candela to Merge
Syneron Medical will purchase aesthetic laser pioneer Candela Corporation for $65 million, creating a global leader in the medical aesthetic device market.
Opexa Shares Soar on Multiple Sclerosis Trial Data
Opexa Therapeutics announced that 83 percent of clinical trial patients taking its therapeutic vaccine Tovaxin remained relapse-free for a year.
FDA Grants Luminex 510(k) Clearance for Cystic Fibrosis Test
The xTAG Cystic Fibrosis 39 Kit v2 is intended to be a faster, more convenient way to screen for CF.
[Company Profile] DATATRAK International
Before a new medical device or drug hits the market, before the flashy ad campaigns, even before government approval, there are clinical trials.
Building a Better Anthrax Vaccine
Swine flu may be causing a current panic, but eight years ago, our big concern was anthrax.
Fall Allergy Season Is Upon Us
Ragweed season is under way, bringing with it sneezes, sniffles, and itchy eyes for 36 million Americans.
Sen. Kennedy Death Puts Focus On Brain Cancer
Glioblastoma multiforme (GBM), the aggressive brain tumor that took Sen. Kennedy’s life, is one of the deadliest brain tumors that can occur in both adults and children.